Вестник войск РХБ защиты (Apr 2024)

Sublines of Omicron Genovariant of SARS-CoV-2 Virus as Potential Dominant Agents of New Rises of COVID-19 Morbidity in Russia

  • T. E. Sizikova,
  • N. V. Karulina,
  • A. A. Petrov,
  • V. N. Lebedev,
  • S. V. Borisevich

DOI
https://doi.org/10.35825/2587-5728-2023-7-4-338-349
Journal volume & issue
Vol. 7, no. 4
pp. 338 – 349

Abstract

Read online

The analysis of existing information about invasion of COVID-19 in Russia shows that that one of leading reason of existing of new rises of covid-19 morbidity is distribution of new genovariants of SARS-CoV-2 virus. The omicron genovariant of SARS-CoV-2 virus was a dominant agent of fifth and subsequent rises of COVID-19 morbidity in Russia. The aim of this work – the estimation of sublines of omicron genovariant of SARS-CoV-2 virus as potential dominant agents of new rises of COVID-19 morbidity in Russia. The source base of the study. Data published in Russian and English-language scientific publications available via the Internet (RSCI, PubMed, Google Scholar). The research method is analytical. Results. The basic properties of omicron genovariant of SARS-CoV-2 virus, epidemical characteristics of the rises of COVID-19 morbidity in Russia, caused by new sublines of omicron variant, estimation ofsublines of omicron genovariant as potential dominant agent of new rises of COVID-19 morbidity in Russia are viewed. It is shown that basic direction of SARS-CoV-2 virus evolution is existing of sublines of omicron genovariant, which are characterized by increased transmissivity but with less severity of the disease caused compared to previously circulated variants of COVID-19agent. The main distinguishing feature of the new subvariants («Kraken», «Czerber», «Centaur», «Arktur», «Pirola») are multiple amino acid exchanges in structural glycoprotein S. The maximum level of variability of this structural protein compared to the original variant of SARS-CoV-2 virus is marked for Pirola subvariant. Onle Kraken subvariant was dominant agent of rise of COVID-19 morbidity in Russia. Conclusion. New rises of COVID-19 morbidity in Russia will not be connected with existing of new subvariants of omicron genovariant, but only with season factor.

Keywords